Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지

신생아 패혈증에서 발현시기에 따른 원인균 분석과 항생제 선택

Analysis of causative microorganisms and choice of antibiotics according to the onset of neonatal sepsis

  • 성준승 (전남대학교 의과대학 소아과학교실) ;
  • 김동연 (전남대학교 의과대학 소아과학교실) ;
  • 김선희 (전남대학교 의과대학 소아과학교실) ;
  • 변형석 (서남대학교 의과대학 소아과학교실) ;
  • 황태주 (전남대학교 의과대학 소아과학교실) ;
  • 최영륜 (전남대학교 의과대학 소아과학교실)
  • Sung, June Seung (Department of Pediatrics, Chonnam University Medical School) ;
  • Kim, Dong Yeon (Department of Pediatrics, Chonnam University Medical School) ;
  • Kim, Sun Hee (Department of Pediatrics, Chonnam University Medical School) ;
  • Byun, Hyung Suk (Department of Pediatrics, Seonam University College of Medicine) ;
  • Hwang, Tai Ju (Department of Pediatrics, Chonnam University Medical School) ;
  • Choi, Young Youn (Department of Pediatrics, Chonnam University Medical School)
  • 투고 : 2006.02.20
  • 심사 : 2006.04.06
  • 발행 : 2006.06.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 신생아 의료의 발전으로 신생아 사망률은 감소하였으나 여러 가지 침습적 시술의 증가로 신생아 패혈증의 발생은 줄어들지 않고 있으며, 아직도 신생아 이환과 사망의 상당한 비중을 차지하고 있다. 전남대학교병원 신생아중환자실에서 신생아 패혈증의 발생시기에 따른 흔한 원인균 및 항생제 감수성 결과를 분석하여 가장 적절한 항생제 선택의 지침을 정하고자 하였다. 방 법 : 2000년 1월 1일부터 2004년 12월 31일까지 전남대학교병원 신생아중환자실에 입원한 환아 중 혈액배양 검사에서 1회(피부 상재균인 경우 2회) 이상 동정된 경우는 89명이었다. 이 중 74명은 패혈증에서 회복된 후 재발하지 않았으며(74례), 12명은 임상증상 재출현과 함께 혈액배양 검사상 균이 1회 더 동정되었고(24례), 3명은 2회 더 동정되어(9례) 총 107례에 대한 입원기록지를 후향적으로 조사하였다. 재태연령, 출생체중, 성별, 주산기 위험인자와 임상증상, 원인균 및 항생제 감수성, 사망률 등을 조사하였다. 결 과 : 신생아 패혈증의 발생빈도는 1.7%였으며, 30주 미만, 출생체중 1,500 g 미만에서 빈발하였다(P<0.05). 조발형의 거의 대부분(92.9%) gram-양성균이 원인이었으나, 지발형에서는 약 2/3(67.4%)가 gram-양성균이고 나머지 1/3은 gram-음성균(20.0%)과 칸디다(12.6%)가 차지하였다. Gram-음성균과 칸디다 감염은 중심정맥 카테테르가 있는 경우에서 많았다. 항생제 감수성 검사상 gram-양성균은 vancomycin, teicoplanin, chloramphenicol 순이었고, gram-음성균은 ciprofloxacin, imipenem, cefotaxime, ceftazidime 순이었다. 결 론 : 신생아 패혈증은 저출생체중 미숙아에서 흔하고, coagulase-negative staphylococci, Candida, S. aureus가 가장 흔한 원인균이었다. 항생제 감수성 검사상 1차 항생제 선택에 조발형은 3세대 cephalosporin 계열과 clindamycin, 지발형은 3세대 cephalosporin 계열과 glycopeptide 계열의 병용이 추천되며, 지발형에서 충분한 항생제 치료에도 반응이 없다면 칸디다 패혈증을 의심하고 예방적 항진균제 사용이 필요할 것으로 사료되었다.

Purpose : The mortality rate of neonatal sepsis has been decreased, however, the incidence has not significantly decreased because of increased invasive procedures. This study was designed to make guidelines for choosing antibiotics by analyzing the causative microorganisms and their antibiotics sensitivity test according to the onset of neonatal sepsis. Methods : One hundred seven cases of culture proven sepsis in 89 patients admitted to the NICU of Chonnam University Hospital from Jan. 2000 to Dec. 2004, were enrolled. By reviewing the medical records, clinical data, laboratory findings, causative organisms and their antibiotics sensitivity, and mortality were analyzed. Results : The incidence of neonatal sepsis was 1.7 percent and more prevalent in premature and low birth weight infants. 85.4 percent of neonatal sepsis was late onset. Almost all microorganisms(92.9 percent) were gram-positive in early onset, however, two thirds were gram-positive and one third were gram-negative and Candida in late onset. Gram-negative organisms and Candida were more prevalent in patients who had central line. Gram-positive organisms were sensitive to vancomycin, teicoplanin, and gram-negative were sensitive to imipenem, and cefotaxime. Conclusion : Neonatal sepsis was more prevalent in premature and low birth weight infants. More than 90 percent were gram-positive in early onset, however, one third was gram-negative and Candida in late onset. The first choice of antibiotics were a combination of third generation cephalosporin and clindamycin in early onset, and third generation cephalosporin and glycopeptide in late onset. If there is no response to antibiotics treatment, the use of antifungal agents should be considered.

키워드

참고문헌

  1. Duham EC. Septicemia in newborn. Am J Dis Child 1933; 45:229-53
  2. Stoumorken A, Powell KR. Sepsis and shock. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelpia : WB Saunders Co, 2003:835-60
  3. Kaplan SL. Bacteremia and septic shock. In : Feign RD, Cherry JD, Demmler GJ, editors. Textbook of pediatric infectious disease. 5th ed. Philadelphia : WB Saunders Co, 2003:810-25
  4. Rudolph AM. Rudolph's pediatrics. 19th ed. East Norwalk Appleton and Lange, 1991:551-9
  5. Freij BJ, McCracken GH Jr. Acute infections. In : Avery GB, Fletcher MA, MacDonald MG. Neonatology-pathophysiology and management of the Newborn. 5th ed. Philadelphia : JB Lippincott Comp, 2003:1189-230
  6. Philip AG, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics 1980;65:1036-41
  7. Park DC, LEE C, Park KI, Namgung R, Han DG. Predictive factors and initial selection of antibiotics in neonatal sepsis. J Korean Pediatr Soc 1991;34:755-62
  8. Lee JK, Cheon HW, Park JH, Lee JH, Lee JW, Kim SK. A clinical study on early diagnosis in neonatal sepsis. J Korean Pediatr Soc 1993:49-56
  9. Baumgart S, Hall SE, Campos JM, Polin RA. Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child 1983;137:461-3
  10. Gotoff SP, Behrman RE. Neonatal septicemia. J Pediatr 1970;76:142-53 https://doi.org/10.1016/S0022-3476(70)80148-2
  11. Wilson HD, Eichenwald HF. Sepsis neonatorum. Pediatr Clin North Am 1974;21:571-82 https://doi.org/10.1016/S0031-3955(16)33025-5
  12. Kim ES, Kim KH. A study of clinical observations in neo-natal sepsis. J Korean Pediatr Soc 1990;33:1180-7
  13. Kim BI, Chung HL, Kim YD, Park WS, Shin SM, Lee HJ, et al. Clinical observations on neonatal sepsis. J Korean Pediatr Soc 1987;30:130-7
  14. Lee JH, Park JJ, Sung IK, Lee CB. Clinical observation in 40 cases with neonatal sepsis. J Korean Pediatr Soc 1990; 33:1489-94
  15. Son JA, Kim SW, Ahn DH, Sohn KC. Clinical observation of neonatal sepsis. J Korean Pediatr Soc 1993;36:671-9
  16. Yong WK, Shin DG, Kim CK, Kwon SJ. Clinical observations in 157 cases with neonatal septicemia. J Korean Pediatr Soc 1975;18:567-75
  17. Yang JS, Namgung R, Lee C, Han DG. Clinical observation in 72 cases with neonatal sepsis. J Korean Pediatr Soc 1986;29:1309-18
  18. Alojipan LC, Andrews BF. Neonatal sepsis. A surgery of eight year's experience at the Louisville General Hospital. Clin Pediatr (Philadelphia) 1975;14:181-5 https://doi.org/10.1177/000992287501400209
  19. Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, Warshaw JB, Baltimore RS. A half century of neonatal sepsis at Yale : 1928 to 1978. Am J Dis Child 1981;135:140-4 https://doi.org/10.1001/archpedi.1981.02130260032010
  20. Soman M, Green B, Daling J. Risk factors for early neonatal sepsis. Am J Epidemiol 1985;121:712-9 https://doi.org/10.1093/aje/121.5.712
  21. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004;51:939-59 https://doi.org/10.1016/j.pcl.2004.03.009
  22. Short MA. Guide to a systemic physical assessment in the infant with suspected infection and/or sepsis. Adv Neonatal Care 2004;4:141-53 https://doi.org/10.1016/j.adnc.2004.04.007
  23. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17:638-80 https://doi.org/10.1128/CMR.17.3.638-680.2004
  24. Kaufman D. Fungal infection in very low birth weight infant. Curr Opin Infect Dis 2004;17:253-9 https://doi.org/10.1097/00001432-200406000-00014
  25. Lee BY, Lee YI, Lee SJ, Choi HW. Clinical and bacteriological observation in cases with neonatal septicemia. J Korean Pediatr Soc 1966;9:61-9
  26. Kim SJ, Cho YJ, Choi SJ. The studies on neonatal septicemia. J Korean Pediatr Soc 1968;11:229-35
  27. Kim KA, Shin SM, Choi JH. A nationwide survey on the causative organisms of neonatal sepsis in Korea. J Korean Pediatr Soc 2002;45:55-63